This study will evaluate the efficacy and safety of clostridial collagenase injections for treatment of Dupuytren's contracture of the thumb and first web space. The investigators hypothesis is that clostridial collagenase will have safety not significantly different to that demonstrated in Phase III clinical trials, and will be effective in significantly reducing the degree of thumb contracture.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
7
Injection of 0.58mg clostridial collagenase into Dupuytren's cord, up to three injections
Indiana Hand to Shoulder Center
Indianaplis, Indiana, United States
Number Patients Obtaining Clinical Improvement (>50% Reduction in Contracture)
Time frame: 30 days after last injection
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.